Center for Scientific Review; Notice of Closed Meetings, 66075 [2011-27545]
Download as PDF
<![CDATA[
Federal Register / Vol. 76, No. 206 / Tuesday, October 25, 2011 / Notices
www.regulations.gov or https://
www.fda.gov/TobaccoProducts/
GuidanceComplianceRegulatory
Information/default.htm.
I. Background
In the Federal Register of June 22,
2011 (76 FR 36628), FDA issued a final
rule regarding required warnings for use
on cigarette packages and in cigarette
advertisements. FDA examined the
economic implications of the final rule
as required by the Regulatory Flexibility
Act (5 U.S.C. 601–612) and determined
that the rule would have a significant
economic impact on a substantial
number of small entities. In compliance
with section 212 of the Small Business
Regulatory Enforcement Fairness Act
(Public Law 104–121), FDA is making
available this SECG stating in plain
language the legal requirements of the
June 22, 2011, final rule, set forth in 21
CFR part 1141, establishing
requirements for graphic health
warnings on cigarette packages and in
cigarette advertisements.
FDA is issuing this SECG as level 2
guidance consistent with FDA’s good
guidance practices regulation (21 CFR
10.115(c)(2)). The SECG represents the
Agency’s current thinking on this topic.
It does not create or confer any rights for
or on any person and does not operate
to bind FDA or the public. An
alternative approach may be used if
such approach satisfies the
requirements of the applicable statutes
and regulations.
sroberts on DSK5SPTVN1PROD with NOTICES
Submit electronic comments on the
guidance to https://www.regulations.gov.
Submit written comments to the
Division of Dockets Management (HFA–
305), Food and Drug Administration,
5630 Fishers Lane, rm. 1061, Rockville,
MD 20852.
FOR FURTHER INFORMATION CONTACT:
Gerie Voss, Center for Tobacco
Products, Food and Drug
Administration, 9200 Corporate Blvd.,
Rockville, MD 20850–3229, 877–287–
1373, gerie.voss@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
National Institutes of Health
II. Comments
Interested persons may submit to the
Division of Dockets Management (see
ADDRESSES) either electronic or written
comments regarding this document. It is
only necessary to send one set of
comments. It is no longer necessary to
send two copies of mailed comments.
Identify comments with the docket
number found in brackets in the
heading of this document. Received
comments may be seen in the Division
of Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday.
III. Electronic Access
Persons with access to the Internet
may obtain an electronic version of this
guidance document at either https://
VerDate Mar<15>2010
18:10 Oct 24, 2011
Jkt 226001
Dated: October 20, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011–27530 Filed 10–24–11; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Small
Business: Non-HIV Diagnostics, Food Safety,
Sterilization/Disinfection and
Bioremediation.
Date: November 17–18, 2011.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites Hotel, 4300 Military
Road, NW., Washington, DC 20015.
Contact Person: Gagan Pandya, PhD,
Scientific Review Officer, National Institutes
of Health, Center for Scientific Review, 6701
Rockledge Drive, RM 3200, MSC 7808,
Bethesda, MD 20892, 301–435–1167,
pandyaga@mai.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Small
Business: Respiratory Sciences.
Date: November 17–18, 2011.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Ghenima Dirami, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4122,
MSC 7814, Bethesda, MD 20892, 301–594–
1321, diramig@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, DA–12–004:
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
66075
The Placebo Effect: Mechanisms and
Methodology (R21).
Date: November 30, 2011.
Time: 9 a.m. to 11:30 a.m.
Agenda: To review and evaluate grant
applications.
Place: Legacy Hotel and Meeting Center,
1775 Rockville Pike, Rockville, MD 20852.
Contact Person: Melissa Gerald, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3172,
MSC 7848, Bethesda, MD 20892, (301) 408–
9107, geraldmel@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, DA–12–003:
The Placebo Effect: Mechanisms and
Methodology (R01).
Date: November 30, 2011.
Time: 11:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Legacy Hotel and Meeting Center,
1775 Rockville Pike, Rockville, MD 20852.
Contact Person: Melissa Gerald, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3172,
MSC 7848, Bethesda, MD 20892, (301) 408–
9107, geraldmel@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: October 19, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–27545 Filed 10–24–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee:
Center for Scientific Review Special
Emphasis Panel Fellowships: AIDS
Predoctoral and Postdoctoral.
E:\FR\FM\25OCN1.SGM
25OCN1
]]>Agencies
[Federal Register Volume 76, Number 206 (Tuesday, October 25, 2011)]
[Notices]
[Page 66075]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-27545]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Small Business: Non-HIV Diagnostics, Food Safety,
Sterilization/Disinfection and Bioremediation.
Date: November 17-18, 2011.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites Hotel, 4300 Military Road, NW.,
Washington, DC 20015.
Contact Person: Gagan Pandya, PhD, Scientific Review Officer,
National Institutes of Health, Center for Scientific Review, 6701
Rockledge Drive, RM 3200, MSC 7808, Bethesda, MD 20892, 301-435-
1167, pandyaga@mai.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, Small Business: Respiratory Sciences.
Date: November 17-18, 2011.
Time: 9 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Ghenima Dirami, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4122, MSC 7814, Bethesda, MD 20892, 301-594-
1321, diramig@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, DA-12-004: The Placebo Effect: Mechanisms and Methodology
(R21).
Date: November 30, 2011.
Time: 9 a.m. to 11:30 a.m.
Agenda: To review and evaluate grant applications.
Place: Legacy Hotel and Meeting Center, 1775 Rockville Pike,
Rockville, MD 20852.
Contact Person: Melissa Gerald, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3172, MSC 7848, Bethesda, MD 20892, (301) 408-
9107, geraldmel@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel, DA-12-003: The Placebo Effect: Mechanisms and Methodology
(R01).
Date: November 30, 2011.
Time: 11:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Legacy Hotel and Meeting Center, 1775 Rockville Pike,
Rockville, MD 20852.
Contact Person: Melissa Gerald, PhD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3172, MSC 7848, Bethesda, MD 20892, (301) 408-
9107, geraldmel@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: October 19, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-27545 Filed 10-24-11; 8:45 am]
BILLING CODE 4140-01-P
